PLx Pharma Inc logo

PLx Pharma Inc

$ 0.62 -0.025 (-3.86%) 10:08 PM EST
P/E:
At Loss
P/B:
1.07
Market Cap:
$ 18.15M
Enterprise V:
$ 18.44M
Volume:
321.33K
Avg Vol (2M):
485.55K
Also Trade In:
Volume:
321.33K
Market Cap $:
18.15M
PE Ratio:
At Loss
Avg Vol (2-Month):
485.55K
Enterprise Value $:
18.44M
PB Ratio:
1.07
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
PLx Pharma Inc is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform designed to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the GI tract. The company believes this platform has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with certain drugs. VAZALORE is a novel formulation of aspirin clinically shown to provide fast, reliable and predictable platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.73
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.33
Distress
Grey
Safe
Beneish M-Score 336.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 60.14
9-Day RSI 47.08
14-Day RSI 39.54
6-1 Month Momentum % -81.56
12-1 Month Momentum % -95.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.57
Quick Ratio 4.15
Cash Ratio 3.94
Days Inventory 146.47
Days Sales Outstanding 42.98
Days Payable 433.68

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -46.6

Financials (Next Earnings Date:2022-11-11 Est.)

PLXP's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PLXP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.774
EPS (TTM) ($) -2.35
Beta 2.7
Volatility % 55.67
14-Day RSI 39.54
14-Day ATR ($) 0.103974
20-Day SMA ($) 0.62718
12-1 Month Momentum % -95.97
52-Week Range ($) 0.463 - 19.83
Shares Outstanding (Mil) 29.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PLx Pharma Inc Filings

Document Form Filing Date
No Filing Data

PLx Pharma Inc Analysis

Share your research

Headlines

See More
No news.